Skip to main content
. 2019 Feb 28;14(2):e0213017. doi: 10.1371/journal.pone.0213017

Fig 2. Flow chart of study participants.

Fig 2

MDR-TB: Multidrug-resistant TB, PMDT: Programmatic Management of Drug-resistant TB, NTM: Non-tuberculous Mycobacteria, DST: phenotypic Drug Susceptibility Testing. *pre-XDR (n = 27) and XDR (n = 3). ** Appropriate treatment was defined as compatibility between DST result and the choice of drug-resistant treatment regimen. ***Patients with DST result not suggesting MDR continued their 2nd line treatment according to Indonesian PMDT guideline. aThe 200 patients were not tested due to possible reasons, which were: 1) patients didn’t present to the laboratory for Xpert testing; 2) patients weren’t able to expectorate sputum.